Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study
一项开放标签、随机、平行组研究，旨在评估接受传统合成疾病修饰抗风湿药（csDMARD）联合地诺单抗治疗的类风湿关节炎患者与仅接受csDMARD治疗的患者相比，通过高分辨率外周定量计算机断层扫描（HR-pQCT）测定的骨侵蚀抑制情况。
期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-022-02957-w
Iwamoto, Naoki; Chiba, Ko; Sato, Shuntaro; Shiraishi, Kazuteru; Watanabe, Kounosuke; Oki, Nozomi; Okada, Akitomo; Koga, Tomohiro; Kawashiri, Shin-Ya; Tamai, Mami; Hosogaya, Naoki; Furuyama, Masako; Kobayashi, Makiko; Saito, Kengo; Okubo, Naoki; Uetani, Masataka; Osaki, Makoto; Kawakami, Atsushi
